Are Medical Stocks Lagging Cronos Group (CRON) This Year?

Impact · against what's priced in

The article provides no actionable catalyst for the stocks mentioned. For Amgen, the moderate estimate growth and YTD returns are already captured in the current valuation; for Cronos Group, the data reflects a positive trend but lacks a specific fundamental trigger to shift current pricing.

AMGN+0.00

Already priced in

The price assumes

raised full-year revenue guidance... and non-GAAP EPS

The article notes positive EPS estimate revisions and strong year-to-date returns, but the price already accounts for raised full-year guidance and the general upward trajectory of the stock.

What AMGN's price assumes · Sep 12

• strong buy▲300%
• healthcare
• AMGN
• CRON
• analyst sentiment
• earnings estimates
• medical

Top 1 mover · tap to explore